%D8%A8%D9%88%D8%B3%D9%84%D9%81%D8%A7%D9%86%D8%A8%D9%88%D8%B3%D9%88%D9%84%D9%81%D8%A7%D9%86Category:BusulfanBwswlffanBusulfanBusulfanBusulf%C3%A1n%D8%A8%D9%88%D8%B3%D9%88%D9%84%D9%81%D8%A7%D9%86BusulfaaniBusulfanBusulfan%E3%83%96%E3%82%B9%E3%83%AB%E3%83%95%E3%82%A1%E3%83%B3%E0%B4%AC%E0%B5%81%E0%B4%B8%E0%B5%BE%E0%B4%AB%E0%B4%BE%E0%B5%BBBusulfanBussulfanoBusulfan%D0%91%D1%83%D1%81%D1%83%D0%BB%D1%8C%D1%84%D0%B0%D0%BDBusulfanBusulfan%D0%91%D1%83%D1%81%D1%83%D0%BB%D1%8C%D1%84%D0%B0%D0%BDBusulfanQ348922%E7%99%BD%E6%B6%88%E5%AE%89
about
Use of Busulfan as Conditioning Agent for a Second Stem Cell TransplantA Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or LymphomasConditioning SCID Infants Diagnosed EarlyDonor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched DonorsComparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationChidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin LymphomaA Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi AnemiaHaplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorReduced Intensity AlloTransplant For OsteopetrosisPhase II Trial of Pentostatin and Targeted BusulfanTreosulfan-based Conditioning for Transplantation in AML/MDSCombination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesBusulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple MyelomaA Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative RegimenDonor Stem Cell Transplantation for Congenital ImmunodeficienciesUmbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseCombination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell TransplantAllogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenReduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseAutologous Stem Cell Transplants for Chronic Myelogenous LeukemiaCyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeBusulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell TransplantationDonor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesBusulfan Pharmacokinetic Analysis and GST Polymorphism in Adults Undergoing Hematological Stem Cell TransplantationHematopoietic Stem Cell Transplant for Fanconi AnemiaFludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesGene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed InfantsT-Cell Depleted Double UCB for Refractory AMLAuto Transplant for High Risk or Relapsed Solid or CNS TumorsPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchMulti-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 RegimenPRO#0118: Decitabine Plus Mini Flu-BuA Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing SarcomaRasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantPhase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell SupportBusulfan and Fludarabine in Patients With AML and MDSAllogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia
P4844
Glutathione conjugation of busulfan produces a hydroxyl radical-trapping dehydroalanine metaboliteResponse of early chick embryos to busulfanGamma-glutamyldehydroalanylglycine is an electrophilic metabolite of glutathioneToxic substances and congenital malformationsThe role of busulfan in bone marrow transplantationBusulfan in hematopoietic stem cell transplantationBusulfan in hematopoietic stem cell transplant setting.Establishment of Effective Mouse Model of Premature Ovarian Failure Considering Treatment Duration of Anticancer Drugs and Natural Recovery TimeThe Effects of Olive Leaf Extract on The Testis, Sperm Quality and Testicular Germ Cell Apoptosis in Male Rats Exposed to BusulfanSynergistic Cytotoxic Effect of Busulfan and the PARP Inhibitor Veliparib in Myeloproliferative Neoplasms
P921
Q59772555-16876218-2475-436B-A0F0-41805BE2BB48Q61894366-C02F2A37-5D27-487F-A01D-9900259C8BCEQ61902774-64F7ED30-01EC-4CC1-AB00-1C89113488C9Q61904952-10FBA653-7E95-48D0-BF42-CCF0A5ED58E0Q61907523-9D711A36-7CF8-4159-8F50-F80F177D914CQ61907577-0D09E200-E64C-4903-8851-3C2E2742F3F5Q61907674-69D801B0-D24F-4371-9B96-2A6B2167118EQ61907988-1C16222B-D898-4ABF-BE37-FB5C063B31D1Q61915079-EB09275B-62C0-4CC8-AD90-DA4EBD38AD5AQ61915090-4DFB33E3-92DA-46D0-9D61-8FACADEB35BDQ61917495-C6405C94-C3F6-4C07-80A7-C9B4FFAC7CABQ61917951-D11AC39F-853A-4B41-A71F-89AD83AD98F3Q61920712-7025C50B-04C8-4EE4-9344-58B9D590D4C5Q61921326-7E62E1A6-B670-46AD-8AFC-BB7E74DDF5ADQ61921334-39D4B14E-E7CF-4799-9802-8D5CF8C66C6BQ61921428-94B7778C-0CD8-4FE1-91A9-AF77179840E4Q61921654-B23655AF-F798-4BDE-A2ED-B6FE55D5F111Q61922326-81138320-8870-4454-A71F-C6F31AEE606DQ61923784-E56C3FAA-970D-457C-8CA5-3811DB71B005Q61924131-7551B6D0-B7C0-4EE9-9365-AF189B1131F7Q61924464-6D6AC352-16B2-45EE-80B5-2052EFC81579Q61924544-B36B5C92-2855-465B-BB2F-4A06E12BB3B9Q61934674-D116DE18-39A0-43DE-98A6-0804BB1A4DFAQ61936868-AEA461D9-52C5-4798-B8DC-A042D488A4C7Q61938686-2DC0D91B-72BC-47AE-A37F-D849990D48B2Q61938712-38BFCFEB-E2EE-41A8-A521-56043C6774D4Q61955568-07038FBA-4B7C-42EE-98DA-D8BF634557CFQ61955600-DB1B86CA-2309-40CA-AA50-4FD498BF673FQ61955757-F808A32E-5BC7-4542-8A3F-CCF64C262483Q61956745-38BE5777-676F-4820-8C7D-1D2AD471C26BQ61957088-DFFA37A2-8CC1-4874-BBAD-8CC246938A01Q61957748-D920D2CA-0754-409C-B5A1-FAEA61F2D2E9Q61965924-99F28341-A613-4E76-B1DF-4DC842A23EB9Q61966137-3574DE09-CD18-4BE5-8584-22C377C9DA23Q61975394-60AA3253-3940-4CC2-8C0C-F25D49746ECCQ61978957-660D8610-00B1-49C2-8205-C3A256493A06Q61979862-B136C024-2B8A-4BD9-BCE2-4A5BAF1EF205Q61980210-6FB178B5-D50E-48B0-AF41-EA93612BE166Q61981266-BA96F3D1-6A10-46A4-91A0-516132B8B895Q61981488-4376CF3C-3CE2-4EA0-B204-1BBA343C334D
P4844
Q23911250-A544AD38-ECA9-4D82-88DE-0B8424F5FA97Q23923765-EFCCF828-39BC-4B0A-9E28-5178BF320662Q26154972-67738415-90A2-4CDB-91F8-6BFC2DAC1DD3Q26324660-686ABE64-1B69-4B56-81DB-269AF309478CQ28374416-A31C4E9A-71B2-4B8F-A33C-BF0BA0B649D4Q34668052-D7FEA70A-4279-427F-9B4C-2368541FFF7CQ37554387-620F0261-801F-49D1-B617-6DE64F3190FAQ60923928-AE8F7FD3-F91D-4F1F-BCF8-3431AAB6082BQ64226799-CD529BFB-D953-4B99-950B-CA55A7AC85DCQ64388251-037A5E7B-2A5B-46F2-BD8E-227169E101FB
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Busulfaani
@fi
Busulfan
@de
Busulfan
@es
Busulfan
@it
Busulfan
@nl
Busulfan
@pl
Busulfan
@ro
Busulfan
@sh
Busulfan
@sr
Busulfan
@vi
type
label
Busulfaani
@fi
Busulfan
@de
Busulfan
@es
Busulfan
@it
Busulfan
@nl
Busulfan
@pl
Busulfan
@ro
Busulfan
@sh
Busulfan
@sr
Busulfan
@vi
altLabel
1,4-Bis(methanesulfonoxy)butane
@cy
1,4-Bis(methanesulfonoxy)butane
@en
1,4-Bis(methylsulfonyloxy)butan
@de
1,4-Butandiol-bis(methansulfonat)
@de
1,4-Butanediol dimethanesulfonate
@cy
1,4-Butanediol dimethanesulfonate
@en
1,4-Dimesyloxybutane
@cy
1,4-Dimesyloxybutane
@en
1,4-Dimethanesulfonoxybutane
@cy
1,4-Dimethanesulfonoxybutane
@en
prefLabel
Busulfaani
@fi
Busulfan
@de
Busulfan
@es
Busulfan
@it
Busulfan
@nl
Busulfan
@pl
Busulfan
@ro
Busulfan
@sh
Busulfan
@sr
Busulfan
@vi